Parathyroid cancer - occurrence, diagnosis, treatment;Rak przytarczyc - wystȩpowanie, diagnostyka, leczenie

Polski Przeglad Chirurgiczny

Volumn 80, Issue 9, 2008, Pages 928-944

  Gawrychowski, Jacek ^a   Kowalski, Grzegorz ^a   Gawrychowska, Agata ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54149105011     PISSN: 0032373X     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10035-008-0072-8     Document Type: Review

References (61)

1. Ła̧cka:Molekularne aspekty etiopatogenezy chorób przytarczyc. Endokrynol Pol 2005; 56: 327-33.
2. Haven CJ, van Puijenbroek M, Karperien M et al.: Differential expression of the calcium sensing receptor and combined loss of chromosome 1q and 11q in parathyroid carcinoma. J Pathol 2004; 202: 86-94.
3. Gołkowski F, Jabrocka-Hybel A, Trafimiuk M i wsp.: Problemy diagnostyczne w rozpoznawaniu pierwotnej nadczynności przytarczyc. Przegl Lek 2005; 62: 685-89.
4. Mendoza V, Hernandez AF, Marquez ML et al.: Primary Hyperparathyroidism Due to Parathyroid Carcinoma. Arch Med Res 1997; 28: 303-06.
5. Ippolito G, Palazzo FF, Sebag F et al.: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg 2007; 94: 566-70.
6. Suliburk JW, Perrier ND: Primary Hyperparathyroidism. Oncologist 2007; 12: 644-53.
7. Agarwal R, Agarwal A, Kar DK et al.: Parathyroid carcinoma. J Assoc Physicians India 2001; 49: 990-93.
8. Ashkenazi D, Elmalah I, Rakover Y et al.: Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma. Am J Otolaryngol 2006; 27: 204-06.
9. Brown JJ, Mhamed H, Williams-Smith L et al.: Primary hyperparathyroidism secondary to simultaneous bilateral parathyroid carcinoma. Ear Nose Throat J 2002; 81: 395-401.
10. Giessler GA, Beech D: Nonfunctional Parathyroid Carcinoma. J Natl Med Assoc 2001; 93: 251-54.
11. Kebebew E, Arici C, Duh QY et al.: Localization and Reoperation Results for Persistent and Recurrent Parathyroid Carcinoma. Arch Surg 2001; 136: 878-85.
12. Shane E: Clinical review 122: Parathyroid Carcinoma. J Clin Endocrinol Metab 2001; 86: 485-93.
13. Wynne AG, van Heerden J, Carney JA et al.: Parathyroid Carcinoma: Clinical and Pathologic Features in 43 Patients. Medicine 1992; 71:197-205.
14. Shaha AR, Ferlito A, Rinaldo A: Distant Metastases from Thyroid and Parathyroid Cancer, ORL. J Otorhinolaryngol Relat Spec 2001; 63: 243-49.
15. Fraker DL: Update on the management of parathyroid tumors. Curr Opin Oncol 2000; 12: 41-48.
16. Dionisi S, Minisola S, Pepe J et al.: Concurrent Parathyroid Adenomas and Carcinoma In the Setting of Multiple Endocrine Neoplasia Type 1: Presentation as Hypercalcemic Crisis. Mayo Clin Proc 2002; 77: 866-69.
17. Hamill J, Maoate K, Beasley SW et al.: Familial parathyroid carcinoma in a child. J Paediatr Child Health 2002; 38: 314-17.
18. Rawat N, Khetan N, Williams DW et al.: Parathyroid carcinoma. Brit J Surg 2005; 92: 1345-53.
19. Hundahl SA, Fleming ID, Fremgen AM et al.: Two Hundred Eighty-Six Cases of Parathyroid Carcinoma Treated in the U.S. between 1985-1995: a National Cancer Date Base report. Cancer 1999; 86: 538-44.
20. Schantz A, Castelman B: Parathyroid carcinoma: a study of 70 cases. Cancer 1973; 31: 600-05.
21. Pelizzo MR, Piotto A, Bergamasco A et al.: Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience. Minerva Endocrinol 2001; 26: 23-29.
22. Rodgers SE, Perrier ND: Parathyroid carcinoma. Curr Opin Oncol 2006; 18: 16-22.
23. Sandelin K, Tullgren O, Farnebo LO: Clinical course of metastatic parathyroid cancer. World J Surg 1994; 18: 594-99.
24. Chang YJ, Mittal V, Remine S et al.: Correlation Between Clinical and Histological Findings in Parathyroid Tumors Suspicious for Carcinoma. Am Surg 2006; 72: 419-26.
25. Hara H, Oyama T, Kimura M et al.: Cytologic Characteristics of Parathyroid Carcinoma: A Case Report. Diagn Cytopathol 1998; 18: 192-98.
26. Favia G, Lumachi F, Polistina F et al.: Parathyroid Carcinoma: Sixteen New Cases and Suggestions for Correct Management. World J Surg 1998; 22: 1225-30.
27. Thompson SD, Prichard AJN: The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 93-97.
28. Clayman G, Gonzalez HE, El-Naggar A et al.: Parathyroid Carcinoma: Evaluation and Interdisciplinary Management. Cancer 2004; 100: 900-05.
29. Bhansali A, Kataria RN, Dutta P et al.: Parathyroid Carcinoma: Difficult Management Options. Indian J Cancer 2002; 39: 119-22.
30. Skrzypek J, Podwiński A, Wieczorek M i wsp.: W sprawie raka przytarczyc. Pol Przegl Chir 1990; 62: 759-67.
31. Cordeiro AC, Montenegro FLM, Kulcsar MAVet al.: Parathyroid carcinoma. Am J Surg 1998; 175: 52-55.
32. Castillo L, Poissonnet G, Haddad A et al.: Parathyroid carcinoma: diagnosis and treatment. Rev Laryngol Otol Rhinol 2000; 121: 169-73.
33. Kebebew E: Parathyroid carcinoma. Curr Treat Options Oncol 2001; 2: 347-54.
34. Barczyński M: Rak przytarczyc - wyzwanie diagnostyczne i problem terapeutyczny. Przegl Lek 2000; 57: 165-67.
35. Shortell CK, Andrus CH, Phillips CE Jr et al.: Carcinoma of the parathyroid gland: 30-year experience. Surgery 1991; 110: 704-08.
36. Jenkins P Satta M, Simmgen M et al.: Metastatic parathyroid carcinoma in the MEN2A syndrome. Clin Endocrinol 1997; 47: 747-51.
37. Obara T, Fujimoto Y: Diagnosis and treatment of patients with parathyroid carcinoma: an update and revive. World J Surg 1991; 15: 738-44.
38. Yamashita K, Suzuki S, Yumita Wet al.: A Case of Familial Isolated Hyperparathyroidism with Ectopic Parathyroid Cancer. Endocr J 2001; 48: 453-58.
39. Snell SB, Gaar EE, Stevens SP et al.: Parathyroid cancer, a continued diagnostic and therapeutic dilemma: report of four cases and review of the literature. Am Surg 2003; 69: 711-16.
40. Bednarek-Tupikowska G, Dunajska K, Milewicz A: Cechy charakterystyczne pierwotnej nadczynności przytarczyc spowodowanej rakiem przytarczyc - na podstawie dwóch przypadków. Przegl Lek 2000; 57: 356-57.
41. Babar-Craig H, Quaglia A, Stearns M: Parathy-roid carcinoma: a report of two casus and a concise review and update of the literature. J Laryngol Otol 2005; 119: 577-80.
42. Kameyama K, Takami H: Double Parathyroid Carcinoma. Endocr J 2003; 50: 477-79.
43. Beus KS, Stack BC Jr: Parathyroid Carcinoma. Otolaryngol Clin North Am 2004; 37: 845-54.
44. Park ST, Condemi G, Shakir KM et al.: Parathyroid Carcinoma: Report of Three Cases and Review of the Literature. Mil Med 1998; 163: 246-49.
45. Kirby-Bott J, Lewis P, Harmer CL et al.: One stage treatment of parathyroid cancer. Eur J Surg Oncol 2005; 31: 78-83.
46. Messerer CL, Bugi SP, Baliski Ch et al.: Normocalcemic parathyroid carcinoma: an unusual clinical presentatio. Word J Sur Oncol 2006; 4: 10.
47. Fujimoto Y, Obara T, Ito Y et al.: Localization and surgical resection of metastatic parathyroid carcinoma. World J Sur 1986; 10: 539-47.
48. Levin KE, Galante M, Clark OH: Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery 1987; 101: 649-60.
49. Wiseman SM, Rigual NR, Hicks WL et al.: Parathyroid carcinoma: A multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 2004; 83: 491-94.
50. Cohn K, Silverman M, Corrado J et al.: Parathyroid carcinoma: The Lahey Clinic experience. Surgery 1985; 12: 1095-1100.
51. Iacobone M, Lumachi F, Favia G: Up-To-Date on Parathyroid Carcinoma: Analysis of an Experience of 19 Cases. J Surg Oncol 2004; 88: 223-28.
52. Kulkarni PS, Parikh PM: The Carcinoma of Parathyroid Gland. Indian J Cancer 2004; 41: 51-59.
53. Sandelin K, Thomson NW, Bondeson L: Metastatic parathyroid carcinoma: dilemmats in management. Surgery 1991; 110: 978-87.
54. Ohara T, Okamoto T, Kanke M et al.: Functioning Parathyroid Carcinoma: Clinicopathologic Features and Rational Treatment. Semin Sujgl Oncol 1997; 13: 134-41.
55. Hoelting T, Weber T, Werner J et al.: Surgical treatment of parathyroid carcinoma. Oncol Rep 2001; 8: 931-34.
56. Chow E, Tsang RW, Brierley JD et al.: Parathyroid carcinoma-the Princess Margaret Hospital experience. Int J Radiot Oncol Biol Phys 1998: 41: 569-72.
57. Kleinpeter KP, Lovato JF, Clark PB et al.: Is Parathyroid Carcinoma Indeed a Lethal Disease. Ann Surg Oncol 2005; 12: 260-66.
58. Shaha AR, Shah J: Parathyroid Carcinoma-A Diagnostic and Therapeutic Challenge. Cancer 1999; 86: 378-80.
59. Bergero N, De Pompa R, Sacerdote C et al.: Gelectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol 2005; 36: 908-14.
60. Kameyama K, Takami H, Umemura S et al.: PCNA and Ki-67 as Prognostic In Human Parathyroid Carcinomas. Ann Surg Oncol 2000; 7: 301-04.
61. Yoshimoto E, Endo H, Tsuyuguchi M et al.: Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clin Endocrinol 1998; 48: 67-72.